Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome
Clinical Journal of Oncology Nursing · 15.07.2026
DOI: 10.1188/26.cjon.s2.e67-e72 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 15.07.2026. Verfasst von Demi M Miller. Beteiligte Einrichtung: Demi M. Miller. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Cytokine Release Syndrome, Immunotherapy, Adoptive, Oncology Nursing. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Chimeric antigen receptor (CAR) T-cell therapy is a promising treatment for certain hematologic malignancies, but many nurses are not trained in caring for two common side effects, cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). OBJECTIVES: This article provides foundational knowledge of CRS and ICANS, including the oncology nurse's role in toxicity monitoring, care coordination, and patient education. METHODS: To support safe, evidence-based CAR T-cell therapy administration, this article discusses grading guidelines, nursing assessments, interventions, and education strategies for CRS and ICANS. FINDINGS: Nurses serve a key role in mitigating CRS and ICANS through early recognition, continuous monitoring, therapeutic intervention, and patient and caregiver education. Using standardized protocols, frequently monitoring vital signs, and performing neurologic assessments optimize patient safety and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Demi M. Miller.
Zitieren
APA
Miller, D. M. (2026). Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.s2.e67-e72
Vancouver
Miller DM. Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.s2.e67-e72
BibTeX
@article{Miller2026,
author = {Miller, Demi M},
title = {Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome},
journal = {Clinical Journal of Oncology Nursing},
year = {2026},
doi = {10.1188/26.cjon.s2.e67-e72}
}
EUVIMED